Autolus Therapeutics plc (AUTL)

Autolus Therapeutics Revenue

Autolus Therapeutics had revenue of $8.98M in the quarter ending March 31, 2025, a decrease of -10.99%. This brings the company's revenue in the last twelve months to $9.01M, down -14.16% year-over-year. In the year 2024, Autolus Therapeutics had annual revenue of $10.12M with 496.00% growth.

• Revenue (ttm): $9.01M
• Revenue Growth: -14.16%
• P/S Ratio: 71.18
• Revenue / Employee: $13,863
• Employees: 650
• Market Cap: 654.71M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	10.12M	8.42M	496.00%
Dec 31, 2023	1.70M	-4.66M	-73.30%
Dec 31, 2022	6.36M	4.03M	172.96%
Dec 31, 2021	2.33M	615.00K	35.86%
Dec 31, 2020	1.72M	-1.19M	-41.02%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.